Capabilities

Small- to large-scale manufacturing

Medix Biochemica Group is proud to say that we were one of the first companies in the world to produce monoclonal antibodies. In the nearly 40 years since, Medix has invested in state-of-the-art technologies to continue to supply the highest quality of monoclonal antibodies while also expanding portfolios and capabilities to become a global, market-leading supplier to the in vitro diagnostics (IVD) industry. We develop, manufacture and market critical raw materials, including antibodies, antigens, enzymes, biologicals and molecular diagnostic reagents for IVD manufacturers globally.

At our Global Headquarters in Espoo, Finland,  we have a long tradition of producing mouse monoclonal antibodies in hybridoma cell lines and in recent years, have adopted recombinant antibody production technology in CHO cells.  To support our monoclonal antibody offering, we have invested in recombinant antigen capabilities, including E.coli and CHO cells, at this site. 

Our USA headquarters, located in St Louis, Missouri,  offers a state-of-the-art,  ISO 13485-certified facility, designed for small to large-scale manufacturing of high quality proteins, antigens and enzymes.

Our molecular diagnostics division, MedixMDx combines quality reagents with comprehensive and diverse expertise in the development and manufactunng of molecular diagnostics kits, making us the partner of choice from concept right through to commercialization

From research to commercialization, our team has the tools, insight and experience you need to grow and succeed.



Processing capacity: milligrams to kilograms

  • Small scale: 5 mL–20 L
  • Medium scale: 20 L–100 L
  • Large scale: 100 L–10,000 L


Example techniques:

  • Extraction: aqueous, solvent detergent, digestion
  • Clarification: precipitation, centrifugation, UF / DF
  • Chromatography: SEC, affinity, ion-exchange
  • Viral clearance: filtration, solvent detergent, pasteurization
  • Final processing blending: lyophilization, formulated liquid
  • Analytical: clinical analyzers, ELISA, electrophoresis, HPLC


Research and development

Medix Biochemica has a robust focus on R&D. With 1 in 4 employees dedicated to design and development of new products, we are able to keep up with every aspect of the IVD industry – from native and recombinant antibodies and antigens to molecular diagnostic reagents. Our customer-centric approach makes us the ideal partner to meet your needs.

Our R&D and analytical teams also use their expertise to develop assay methods, purification schemes, and tailor or scale up processes to deliver the right product and solutions for our clients' final application. Read more about our R&D capabilities.

Please get in touch with us today to discuss your bespoke needs.